...
首页> 外文期刊>Acta biomaterialia >Nanostructural control of the release of macromolecules from silica sol-gels.
【24h】

Nanostructural control of the release of macromolecules from silica sol-gels.

机译:从二氧化硅溶胶凝胶中释放大分子的纳米结构控制。

获取原文
获取原文并翻译 | 示例

摘要

The therapeutic use of biological molecules such as growth factors and monoclonal antibodies is challenging in view of their limited half-life in vivo. This has elicited the interest in delivery materials that can protect these molecules until released over extended periods of time. Although previous studies have shown controlled release of biologically functional BMP-2 and TGF-β from silica sol-gels, more versatile release conditions are desirable. This study focuses on the relationship between room temperature processed silica sol-gel synthesis conditions and the nanopore size and size distribution of the sol-gels. Furthermore, the effect on release of large molecules with a size up to 70kDa is determined. Dextran, a hydrophilic polysaccharide, was selected as a large model molecule at molecular sizes of 10, 40 and 70kDa, as it enabled us to determine a size effect uniquely without possible confounding chemical effects arising from the various molecules used. Previously, acid catalysis was performed at a pH value of 1.8 below the isoelectric point of silica. Herein the silica synthesis was pursued using acid catalysis at either pH 1.8 or 3.05 first, followed by catalysis at higher values by adding base. This results in a mesoporous structure with an abundance of pores around 3.5nm. The data show that all molecular sizes can be released in a controlled manner. The data also reveal a unique in vivo approach to enable release of large biological molecules: the use more labile sol-gel structures by acid catalyzing above the pH value of the isoelectric point of silica; upon immersion in a physiological fluid the pores expand to reach an average size of 3.5nm, thereby facilitating molecular out-diffusion.
机译:考虑到它们在体内的半衰期有限,生物分子例如生长因子和单克隆抗体的治疗用途具有挑战性。这引起了对可以保护这些分子直至长时间释放的传递材料的兴趣。尽管先前的研究表明从二氧化硅溶胶凝胶中控制释放生物功能性BMP-2和TGF-β,但更通用的释放条件是理想的。这项研究集中在室温处理的二氧化硅溶胶-凝胶合成条件与纳米孔尺寸和溶胶-凝胶尺寸分布之间的关系。此外,确定了对释放大小最大为70kDa的大分子的影响。葡聚糖是一种亲水性多糖,被选为分子大小为10、40和70kDa的大型模型分子,因为它使我们能够唯一确定大小效应,而不会混淆所使用的各种分子所产生的化学效应。以前,酸催化是在低于二氧化硅等电点的pH值为1.8的条件下进行的。本文中,首先使用酸催化在pH 1.8或3.05下进行二氧化硅合成,然后通过添加碱以更高的值进行催化。这导致具有约3.5nm的大量孔的中孔结构。数据表明,所有分子大小均可以受控方式释放。数据还揭示了一种独特的体内方法,能够释放大的生物分子:通过在二氧化硅等电点的pH值以上进行酸催化,使用更不稳定的溶胶-凝胶结构;浸入生理流体后,毛孔会膨胀,达到3.5nm的平均大小,从而促进分子向外扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号